What is insulin resistance pathway?

Insulin resistance pathway (IR) is a key metabolic dysfunction where the body’s cells become less responsive to insulin, leading to elevated blood glucose levels. This pathway is essential for understanding conditions such as type 2 diabetes, obesity, and metabolic syndrome. IR is influenced by various molecular mechanisms including inflammatory pathways, altered lipid metabolism, and dysregulated insulin signaling.

Why Choose AnyGenes® for Insulin Resistance Research?

AnyGenes^® offers advanced qPCR arrays for comprehensive analysis of the insulin resistance pathway. With our solutions, researchers can:

Investigate key regulators involved in IR such as IRS-1, GLUT4, and the PI3K/Akt pathway.
Analyze gene expression in insulin signaling and glucose metabolism.
Explore the crosstalk between IR and other metabolic pathways, including inflammation and oxidative stress.

Our qPCR arrays deliver precise and reproducible results, helping to advance research on insulin resistance mechanisms and their role in metabolic diseases.

Discover our advanced qPCR arrays for Insulin Resistance research.

An integrated physiological signaling on different target tissues insulin resistance.

Key components of the insulin resistance pathway

The IR pathway involves a complex interplay of signaling molecules and cellular processes:

Insulin Receptors (IR): Insulin binds to its receptor on target cells, initiating downstream signaling to regulate glucose uptake and metabolism.
IRS Proteins (Insulin Receptor Substrates): These proteins mediate the signaling cascade after insulin binding, playing a crucial role in glucose metabolism.
PI3K/Akt Pathway: A critical signaling pathway involved in glucose uptake, cell growth, and survival. Dysregulation of this pathway is a hallmark of IR.
Glucose Transporters (GLUT4): In muscle and fat cells, GLUT4 facilitates the uptake of glucose in response to insulin. Impaired GLUT4 translocation is a key feature of IR.

Key biomarkers in IR research

Identifying and studying biomarkers associated with insulin resistance can help early detection and guide treatment strategies. Some key biomarkers linked to IR include:

IRS-1: Insulin Receptor Substrate 1 is critical for insulin signal transduction. Reduced activity of IRS-1 is often observed in insulin resistance.
GLUT4: Glucose transporter 4 is responsible for glucose uptake in muscle and fat cells. Impaired translocation of GLUT4 is a hallmark of IR.
TNF-α and IL-6: These inflammatory cytokines are elevated in individuals with insulin resistance and contribute to the inflammatory environment that worsens metabolic dysfunction.
Adiponectin: An adipokine that promotes insulin sensitivity. Decreased levels of adiponectin are often seen in individuals with obesity and insulin resistance.

Metabolic diseases related to IR

IR is central to the development of various diseases:

Type 2 Diabetes: Chronic IR leads to elevated blood glucose levels, a hallmark of type 2 diabetes.
Obesity: Obesity exacerbates IR, particularly through increased fat accumulation in visceral (abdominal) fat cells. Adipose tissue releases inflammatory cytokines and free fatty acids, which contribute to insulin resistance in muscle, liver, and fat cells. Understanding how excess fat affects insulin signaling can help guide interventions to prevent or treat obesity-related IR.
Cardiovascular Diseases: IR is associated with an increased risk of cardiovascular diseases. The condition causes higher blood sugar levels, increased cholesterol levels, and higher blood pressure, all of which are risk factors for heart disease. Inflammatory responses linked to IR also play a critical role in the development of atherosclerosis and other cardiovascular complications.
Non-Alcoholic Fatty Liver Disease (NAFLD): NAFLD is one of the most common liver conditions worldwide and is often linked to IR. Excess fat accumulation in the liver, combined with impaired insulin signaling, leads to inflammation and liver damage.

Causes of insulin resistance

IR is caused by a combination of lifestyle choices, genetic factors, and environmental influences.

Obesity: Excess fat, especially abdominal fat, secretes inflammatory substances that disrupt insulin function, promoting IR.
Physical Inactivity: Sedentary lifestyles reduce the body’s ability to use insulin effectively, leading to IR.
Poor Diet: A diet high in refined sugars, unhealthy fats, and processed foods can overwhelm the insulin system, causing resistance over time.
Genetics: Family history and genetic factors play a role in increasing susceptibility to IR.
Hormonal Imbalances: Conditions like PCOS, Cushing’s syndrome, and thyroid disorders can interfere with insulin sensitivity.
Chronic Stress: High cortisol levels from prolonged stress can impair insulin function, contributing to IR.
Sleep Disorders: Poor sleep or conditions like sleep apnea can disrupt insulin regulation and increase the risk of resistance.
Inflammation: Chronic inflammation from excess fat or other factors interferes with insulin signaling, worsening resistance.
Aging: As people age, insulin sensitivity naturally declines, increasing the risk of IR.
Smoking: Smoking increases oxidative stress and inflammation, disrupting insulin function and promoting resistance.

Altered interorgan crosstalk underlying the development of insulin resistance and possible therapeutic strategies.

Analyze your pathway data with AnyGenes® software

Scientific data is only as powerful as the analysis behind it.

AnyGenes® provides a dedicated data analysis tool specifically developed for SignArrays® pathway panels.

What does it allow you to do?

Automated ΔCq calculation
Normalization with selected housekeeping genes
Comparison of up to 10 experimental conditions
Generation of descriptive statistics
Publication-ready graphs
Exportable tables for manuscripts and presentations

Developed on Excel (compatible with 2007+), the software is user-friendly and requires no advanced bioinformatics skills.

Customize your own signaling pathways (SignArrays®) with the factors of your choice!
Simply download and complete our Personalized SignArrays® information file and send it at [email protected] to initiate your project.

Insulin resistance signaling pathway biomarker list

You can check the biomarker list included in this pathway, see below:

Species : Homo sapiens (human)

Human insulin resistance

Signaling Pathways	Product ref	Informations
Insulin Resistance	*******	Biomarker list in progress.

Species : Mus musculus (mouse)

Mouse Insulin Resistance

Signaling Pathways	Product ref	Informations
Insulin Resistance	IR1M1	Download biomarker list

Species : Rattus norvegicus (rat)

Rat Insulin Resistance

Signaling Pathways	Product ref	Informations
Insulin Resistance	*******	Biomarker list in progress.

Species : Sus Scrofa (Pig)

Pig Adipogenesis

Signaling Pathways	Product ref	Informations
Insulin Resistance	*******	Biomarker list in progress.

Looking for more answers? Visit our Help & FAQ section to find detailed informations about our products, services, and technical support.

Bibliography

1. Li M, et al. Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduct Target Ther. (2022);7(1):216.

2. Kellar D, et Craft S. Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches. Lancet Neurol. (2020);19(9):758-766.

3. Takano C, et al. Insulin Resistance in Mitochondrial Diabetes. Biomolecules. (2023);13(1):126.

4. Mastrototaro L, et Roden M. Insulin resistance and insulin sensitizing agents. Metabolism. (2021);125:154892.

Need pricing information or distributor details?
For quotations, product information, or project discussions, please contact our team at [email protected].